ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 660027 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 660027; 2) Community: the network communities that were significantly associated with the response to NSC 660027; 3) Molecule: the relationships between components within communities and NSC 660027; 4) MDR: the compounds that were significantly associated with the NSC 660027.

NSC Compound Enrichment Correlation
NSC 660313 Null 0.0385613993886001 0.20355239
NSC 666138 Null 0.0385613993886001 0.17777482
NSC 674182 Null 0.0385613993886001 0.56909288
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0385613993886001 0.056249574
NSC 681632 Camptothecin Derivative 0.0385613993886001 0.60719603
NSC 681633 Camptothecin Derivative 0.0385613993886001 0.53737784
NSC 681641 Camptothecin Derivative 0.0385613993886001 0.40765556
NSC 683039 Immunotoxin e23(dsFv)-PE38, anti-c-erbB-2 disulfide -stabilized Fv genetically fused to truncated form of Pseudomonas exotoxin 0.0385613993886001 -0.15677714
NSC 685828 7H-Purine, 6-chloro-7-[2-deoxy-3-O-(4-methylphenyl)- 4-(4-methylphenoxy)-.beta.-D-erythrofuranosyl]- 0.0385613993886001 0.40418712
NSC 688028 Null 0.0385613993886001 0.20631813
Total:52  Current:36    [First] [Prev] [Next] [Last]